Key Takeaways
- Lupin settled US patent-infringement litigation with Harmony Biosciences over its proposed generic Wakix (pitolisant hydrochloride).
Lupin must wait until at least January 2030 to launch its proposed generic of
Lupin Concedes To Harmony On Generic Wakix With 2030 Launch Agreement
Lupin became the latest ANDA sponsor to settle patent-infringement litigation over Harmony Biosciences’ Wakix (pitolisant hydrochloride), which has been touted as a potential blockbuster.
